Beta Bionics Announces Participation at Upcoming Investor Conferences
Beta Bionics (Nasdaq: BBNX) announced management will present at two upcoming investor conferences in November and December 2025. Presentations are scheduled for Wolfe Research 7th Annual Healthcare Conference on November 18, 2025 at 2:00 PM ET and Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 at 4:30 PM ET. Both sessions will be webcast live and archived for replay. Webcast links will be posted in the company’s Investors & Events section at https://investors.betabionics.com.
Beta Bionics (Nasdaq: BBNX) ha annunciato che la direzione parteciperà a due prossime conferenze per investitori a novembre e dicembre 2025. Le presentazioni sono previste presso Wolfe Research 7th Annual Healthcare Conference il 18 novembre 2025 alle 14:00 ET e presso Piper Sandler 37th Annual Healthcare Conference il 2 dicembre 2025 alle 16:30 ET. Entrambe le sessioni saranno trasmesse in diretta webcast e successivamente disponibili in replay. I link per il webcast saranno pubblicati nella sezione Investitori & Eventi della società all'indirizzo https://investors.betabionics.com.
Beta Bionics (Nasdaq: BBNX) anunció que la dirección presentará en dos conferencias de inversores próximas en noviembre y diciembre de 2025. Las presentaciones están programadas para Wolfe Research 7th Annual Healthcare Conference el 18 de noviembre de 2025 a las 2:00 PM ET y Piper Sandler 37th Annual Healthcare Conference el 2 de diciembre de 2025 a las 4:30 PM ET. Ambas sesiones serán transmitidas en vivo por webcast y estarán disponibles en archivo para su reproducción. Los enlaces del webcast se publicarán en la sección de Inversores y Eventos de la empresa en https://investors.betabionics.com.
Beta Bionics (나스닥: BBNX)는 2025년 11월과 12월의 두 차례 다가오는 투자자 컨퍼런스에서 경영진이 발표할 것이라고 발표했습니다. 발표는 Wolfe Research 7th Annual Healthcare Conference에서 2025년 11월 18일 오후 2:00 ET와 Piper Sandler 37th Annual Healthcare Conference에서 2025년 12월 2일 오후 4:30 ET에 예정되어 있습니다. 두 세션 모두 실시간 웹캐스트로 방송되며 재생을 위해 보관됩니다. 웹캐스트 링크는 회사의 Investors & Events 섹션의 https://investors.betabionics.com에 게시될 예정입니다.
Beta Bionics (Nasdaq: BBNX) a annoncé que la direction participera à deux prochaines conférences pour investisseurs en novembre et décembre 2025. Les présentations sont prévues pour la Wolfe Research 7th Annual Healthcare Conference le 18 novembre 2025 à 14h00 ET et la Piper Sandler 37th Annual Healthcare Conference le 2 décembre 2025 à 16h30 ET. Les deux sessions seront diffusées en direct par webcast et archivées pour être rejouées. Des liens de webcast seront publiés dans la section Investisseurs & Événements de la société sur https://investors.betabionics.com.
Beta Bionics (Nasdaq: BBNX) gab bekannt, dass das Management bei zwei bevorstehenden Investorenkonferenzen im November und Dezember 2025 präsentieren wird. Die Präsentationen sind vorgesehen für Wolfe Research 7th Annual Healthcare Conference am 18. November 2025 um 14:00 Uhr ET und Piper Sandler 37th Annual Healthcare Conference am 2. Dezember 2025 um 16:30 Uhr ET. Beide Sitzungen werden live per Webcast gestreamt und stehen anschließend zur Wiedergabe bereit. Webcast-Links werden in der Sektion Investors & Events des Unternehmens unter https://investors.betabionics.com veröffentlicht.
بيتا بايونكس (ناسداك: BBNX) أعلنت أن الإدارة ستقدم في مؤتمرين قادمين للمستثمرين في نوفمبر وديسمبر 2025. من المقرر أن تتضمن العروض مؤتمر Wolfe Research الصحي السنوي السابع في 18 نوفمبر 2025 الساعة 2:00 مساءً بتوقيت شرق الولايات المتحدة و مؤتمر Piper Sandler الصحي السنوي الثالث والسبعون في 2 ديسمبر 2025 الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة. كلا الجلستين ستكونان بثًا حيًا عبر الويب ومخزّنتين لإعادة التشغيل. ستُنشر روابط البث عبر الويب في قسم المستثمرين والفعاليات بالشركة على https://investors.betabionics.com.
- None.
- None.
IRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two upcoming investor conferences (all Eastern Time):
- Wolfe Research 7th Annual Healthcare Conference on Tuesday, November 18, 2025 at 2:00pm
- Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:30pm
The presentations will be webcast live. The link to the webcasts will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the events.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
When will Beta Bionics (BBNX) present at the Wolfe Research Healthcare Conference?
When will Beta Bionics (BBNX) present at the Piper Sandler Healthcare Conference?
Where can investors watch the Beta Bionics (BBNX) conference webcasts live?
Will Beta Bionics (BBNX) archive the conference presentations for replay?
What topics will Beta Bionics (BBNX) management cover at the November–December 2025 conferences?
